Edition:
United Kingdom

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

0.50USD
16 Nov 2018
Change (% chg)

$0.05 (+10.87%)
Prev Close
$0.45
Open
$0.45
Day's High
$0.51
Day's Low
$0.44
Volume
79,071
Avg. Vol
146,629
52-wk High
$3.57
52-wk Low
$0.44

Chart for

About

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $187.67
Shares Outstanding(Mil.): 41.07
Dividend: --
Yield (%): --

Financials

  ADXS.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -2.29 -- --
ROI: -105.74 -0.64 15.05
ROE: -116.33 0.08 16.62

Earnings vs. Estimates